期刊文献+

胰岛自身抗体检测及其临床应用 被引量:6

暂未订购
导出
摘要 1型糖尿病(T1DM)是由致病性T淋巴细胞介导的以胰岛B细胞进行性破坏为特征的自身免疫性疾病。自身反应性T淋巴细胞破坏胰岛p细胞,使得存在于胰岛细胞内的自身抗原释放,被B淋巴细胞识别,从而产生抗体。
出处 《广东医学》 CAS CSCD 北大核心 2012年第18期2703-2705,共3页 Guangdong Medical Journal
  • 相关文献

参考文献19

  • 1KAWASAKI E, KURIYA G, SATOH T, et al. Humeral immune response to islet autoantigens in Japanese patients with type 1 dia- betes[J]. Ann N Y Acad Sci, 2008, 1150:248 -251.
  • 2BARJER J M, MCFANN K K, ORBAN T. Effect of oral insulin on insulin autoantibody levels in the Diabetes Prevention Trial Type 1 oral insulin study [ J]. Diabetologia, 2007, 50 (8): 1603 - 1606.
  • 3DEVENDRA D, GALLOWAY T S, HORTON S J, et al. The use of phage display to distinguish insulin autoantibody (IAA) from insulin antibody (IA) idiotypes [ J ]. Diabetologia, 2003,46 ( 6 ) : 802 - 809.
  • 4BINGLEY P J, BONIFACIO E, MUELLER P W. Diabetes Anti- body Standardization Program: first assay proficiency evaluation [J]. Diabetes, 2003, 52(5): 1128-1136.
  • 5CHIMIENTI F, DEVERGNAS S, PATTOU F, et al. In vivo ex- pression and functional characterization of the zinc transporter ZnT8 in glucose- induced insulin secretion [ J ]. J Cell Sci, 2006, 119 (Pt 20) : 4199 -4206.
  • 6SLADEK R, ROCHELEU G, RUNG J, et al. A genome - wide association study identifies novel risk loci for type 2 diabetes [ J ]. Nature, 2007, 445(7130) : 881 -885.
  • 7WENZLAU J M, WALTER M, GARDNER T J, et al. Kinetics of the post - onset decline in zinc transporter $ autoantibodies in type 1 diabetic human subjects [ J ]. J Clin Endocrinol Metab, 2010, 95(10) : 4712 -4719.
  • 8BINGLEY P J, GALE E A. Progression to type 1 diabetes in islet cell antibody - positive relatives in the European Nicotinamide Dia- betes Intervention Trial: the role of additional immune, genetic and metabolic markers of risk [ J ]. Diabetologia, 2006, 49 ( 5 ) : 881 - 890.
  • 9ZIEGLER A G, HUMMEL M, SCHENKER M, et al. Autoantibody appearance and risk for development of childhood diabetes in offspring of parents with type 1 diabetes : The 2 - year analysis of the German BABYDIAB study[J]. Diabetes, 1999, 48(3) : 460 -468.
  • 10GARDNER S G, GALE E A, WILLIAMS A J, et al. Progression to diabetes in relatives with islet autoantibodies, Is it inevitable? [ J]. Diabetes Care, 1999, 22 (12) : 2049 - 2054.

同被引文献43

  • 1Grossi A, Palma A, Fierabracci A, et al. Muhiorgan autoimmunity in a Turner syndrome patient with partial monosomy 2q and trisomy 10p[ J]. Gene, 2013,515:439-443.
  • 2Bahn RS, Burch HB, Cooper DS, et al. Hyperthyroidism and other causes of thyrotoxicosis: American Thyroid Association management guidelines of the and American Association of Clinical Endocrinologists[ J]. Endoer Pract,2011,17 :456-520.
  • 3Pihoker C, Gilliam LK, Hampe CS, et al. Autoantibodies in diabetes [ J ]. Diabetes,2005,54 Suppl2 : S52-61.
  • 4Wenzlan JM, Walter M, Gardner TJ, et al. Kinetics of the post- onset decline in zinc transporter 8 autoantibodies in type 1 diabetic human subjects [ J]. J Clin Endocrinol Metab, 2010, 95: 4712-4719.
  • 5Ziegler AG, Rewers M, Simell O, et al. Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children [ J]. JAMA,2013,309:2473-2479.
  • 6Pescovitz MD, Greenbaum C J, Krause-Steinrauf H, et al. Rituximab, B-lymphocyte depletion, and preservation of beta-cell function[J]. N Engl J Med,2009,361:2143-2152.
  • 7Jorgensen KT, Rostgaard K, Bache I, et al. Autoimmune diseases in women with Turner' s syndrome [ J ]. Arthritis Rheum, 2010, 62:658-666.
  • 8Mortensen KH, Cleemann L, Hjerrild BE, et al. Increased prevalence of autoimmunity in Turner syndrome--influence of age [ J]. Clin Exp Immunol,2009 ,156 :205-210.
  • 9Lleo A, Moroni L, Caliari L, et al. Autoimmunity and Turner's syndrome[ J]. Autoimmun Rev, 2012,11 : A538-543.
  • 10Bakalov VK, Gutin L, Cheng CM, et al. Autoimmune disorders in women with turner syndrome and women with karyo typically normal primary ovarian insufficiency[J]. J Autoimmun,2012,38: 315-321.

引证文献6

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部